MediWound (MDWD) EBITDA (2013 - 2025)
MediWound (MDWD) recorded quarterly EBITDA of -$7.2 million in Q4 2025, down 170.01% quarter-over-quarter from -$2.7 million in Q3 2025, and down 84.04% on a YoY basis from -$45.0 million in Q4 2024.
MediWound (MDWD) EBITDA (2013 - 2025) Analysis & Trends
MediWound's EBITDA history runs 13 years deep, the most recent figure standing at -$7.2 million for Q4 2025.
- In Q4 2025, EBITDA fell 84.04% year-over-year to -$7.2 million; the TTM figure through Dec 2025 stood at $2.8 million (up 115.66% YoY), while the FY2025 annual figure was -$23.9 million, up 20.91% from the prior year.
- EBITDA was -$7.2 million for Q4 2025 at MediWound, down from -$2.7 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $13.3 million in Q2 2025 to a low of -$10.3 million in Q3 2024.
- Historically, EBITDA has averaged -$3.0 million across 5 years, with a median of -$3.6 million in 2022.
- Biggest YoY gain for EBITDA was 257.3% in 2024; the steepest drop was 370.03% in 2024.
- A 5-year view of EBITDA shows it stood at -$4.2 million in 2021, then sank by 80.0% to -$7.5 million in 2022, then soared by 76.54% to -$1.8 million in 2023, then plunged by 122.58% to -$3.9 million in 2024, then sank by 84.04% to -$7.2 million in 2025.
- The last three EBITDA figures came in at -$7.2 million (Q4 2025), -$2.7 million (Q3 2025), and $13.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | -7.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.19 Mn |
| Sep 30, 2025 | -2.66 Mn |
| Jun 30, 2025 | 13.33 Mn |
| Mar 31, 2025 | -725,000.00 |
| Dec 31, 2024 | -3.90 Mn |
| Sep 30, 2024 | -10.29 Mn |
| Jun 30, 2024 | 6.30 Mn |
| Mar 31, 2024 | -9.72 Mn |
| Dec 31, 2023 | -1.75 Mn |
| Sep 30, 2023 | -2.19 Mn |
| Jun 30, 2023 | -4.01 Mn |
| Mar 31, 2023 | -3.70 Mn |
| Dec 31, 2022 | -7.48 Mn |
| Sep 30, 2022 | -4.19 Mn |
| Jun 30, 2022 | -4.34 Mn |
| Mar 31, 2022 | -3.58 Mn |
| Dec 31, 2021 | -4.15 Mn |
| Sep 30, 2021 | -3.34 Mn |
| Jun 30, 2021 | -3.20 Mn |
| Mar 31, 2021 | -2.84 Mn |